Sun Pharmaceutical Industries Ltd. closed 13.65% short of its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in the US, as per some estimates.

Products like laptops, smartphones and the components needed to make them accounted for nearly $174 billion in U.S. imports from China last year. The administration’s plans suggest that such ...